Literature DB >> 6201609

A modulatory octopaminergic neurone increases cyclic nucleotide levels in locust skeletal muscle.

P D Evans.   

Abstract

Octopamine increases the level of cyclic AMP in a dose-dependent way in the locust extensor tibiae neuromuscular preparation. The response peaks after a 10 min exposure and then declines to a plateau. The effect of octopamine is potentiated in the presence of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX). The levels of cyclic GMP in the muscle were not affected by octopamine. The response is stereospecific for the naturally occurring D(-) isomer of octopamine and is also specific for monophenolic biogenic amines. Studies with a range of synthetic agonists and antagonists reveal that the receptors mediating the response are of the OCTOPAMINE2 class. Forskolin, a diterpene activator of adenylate cyclase activity, increases cyclic AMP but not cyclic GMP levels in the extensor muscle. The response has a prolonged time course and is again potentiated by IBMX. Stimulation of the octopaminergic neurone to the extensor muscle increases the levels of cyclic AMP but not those of cyclic GMP. The response is blocked by phentolamine, an alpha-adrenergic blocking agent that also blocks the effects of octopamine in this preparation. The results are discussed in terms of the parallels between the biochemical and physiological effects of octopamine on this muscle and in terms of the mode of action of the octopamine receptors present.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201609      PMCID: PMC1199404          DOI: 10.1113/jphysiol.1984.sp015112

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  43 in total

1.  The effects of adrenaline, noradrenaline and isoprenaline on skeletal muscle contractions in the cat.

Authors:  W C BOWMAN; E ZAIMIS
Journal:  J Physiol       Date:  1958-11-10       Impact factor: 5.182

2.  Relationship between hormonal activation of phosphatidylinositol hydrolysis, fluid secretion and calcium flux in the blowfly salivary gland.

Authors:  J N Fain; M J Berridge
Journal:  Biochem J       Date:  1979-01-15       Impact factor: 3.857

3.  Saturation assay for cyclic AMP using endogenous binding protein.

Authors:  B L Brown; R P Ekins; J D Albano
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

4.  Effects of catecholamines, cyclic nucleotides and phosphodiesterase inhibitors on contractions of skeletal muscles in anaesthetized cats.

Authors:  W C Bowman; M W Nott
Journal:  Clin Exp Pharmacol Physiol       Date:  1974 Jul-Aug       Impact factor: 2.557

5.  Glutamate regulates adenylate cyclase and guanylate cyclase activities in an isolated membrane preparation from insect muscle.

Authors:  N L Robinson; P M Cox; P Greengard
Journal:  Nature       Date:  1982-03-25       Impact factor: 49.962

Review 6.  Possible role for cyclic nucleotides and phosphorylated membrane proteins in postsynaptic actions of neurotransmitters.

Authors:  P Greengard
Journal:  Nature       Date:  1976-03-11       Impact factor: 49.962

7.  Localization of beta adrenergic receptors, and effects of noradrenaline and cyclic nucleotides on action potentials, ionic currents and tension in mammalian cardiac muscle.

Authors:  H Reuter
Journal:  J Physiol       Date:  1974-10       Impact factor: 5.182

8.  Multiple receptor types for octopamine in the locust.

Authors:  P D Evans
Journal:  J Physiol       Date:  1981-09       Impact factor: 5.182

Review 9.  Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

Authors:  K B Seamon; J W Daly
Journal:  J Cyclic Nucleotide Res       Date:  1981

10.  Octopamine mediated relaxation of maintained and catch tension in locust skeletal muscle.

Authors:  P D Evans; M V Siegler
Journal:  J Physiol       Date:  1982-03       Impact factor: 5.182

View more
  13 in total

Review 1.  Insect octopamine receptors: a new classification scheme based on studies of cloned Drosophila G-protein coupled receptors.

Authors:  Peter D Evans; Braudel Maqueira
Journal:  Invert Neurosci       Date:  2005-10-24

2.  Characterization of octopamine-sensitive adenylate cyclase: elucidation of a class of potent and selective octopamine-2 receptor agonists with toxic effects in insects.

Authors:  J A Nathanson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

Review 3.  Octopamine receptor subtypes and their modes of action.

Authors:  P D Evans; S Robb
Journal:  Neurochem Res       Date:  1993-08       Impact factor: 3.996

4.  A concentration-dependent localization of octopamine-sensitive adenylate cyclase activity in locust skeletal muscle.

Authors:  L S Swales; P D Evans
Journal:  Histochemistry       Date:  1989

5.  Changes in prostaglandin E2 and F2 alpha during vitellogenesis in the Florida crayfish Procambarus paeninsulanus.

Authors:  E P Spaziani; G W Hinsch; S C Edwards
Journal:  J Comp Physiol B       Date:  1993       Impact factor: 2.200

6.  Histochemical localization of octopamine- and proctolin-sensitive adenylate cyclase activity in a locust skeletal muscle.

Authors:  L S Swales; P D Evans
Journal:  Histochemistry       Date:  1988

Review 7.  Essential oils and their compounds as Aedes aegypti L. (Diptera: Culicidae) larvicides: review.

Authors:  Clarice Noleto Dias; Denise Fernandes Coutinho Moraes
Journal:  Parasitol Res       Date:  2013-11-22       Impact factor: 2.289

8.  Regional differences in responsiveness to octopamine within a locust skeletal muscle.

Authors:  P D Evans
Journal:  J Physiol       Date:  1985-09       Impact factor: 5.182

9.  The role of cyclic nucleotides in modulation of the membrane potential of the Schwann cell of squid giant nerve fibre.

Authors:  P D Evans; V Reale; J Villegas
Journal:  J Physiol       Date:  1985-06       Impact factor: 5.182

10.  The role of cyclic nucleotides and calcium in the mediation of the modulatory effects of octopamine on locust skeletal muscle.

Authors:  P D Evans
Journal:  J Physiol       Date:  1984-03       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.